- Presentations
- 4
- Markets
- 1
Sovaldi is a brand of Sofosbuvir marketed by Gilead Sciences, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Sofosbuvir
- Brand owner
- Gilead Sciences
- Registered in
- United States
- Strengths and forms
- 150 mg oral pellets, 200 mg oral pellets, 200 mg tablet, 400 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Sovaldi 150 mg oral pelletsOral | Gilead Sciences | US FDA | Available on request |
| Sovaldi 200 mg oral pelletsOral | Gilead Sciences | US FDA | Available on request |
| Sovaldi 200 mg tabletOral | Gilead Sciences | US FDA | Available on request |
| Sovaldi 400 mg tabletOral | Gilead Sciences | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Sovaldi
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.